Showing results (141-150 of 324) with videos related to

Sort By:
Pageof 33
American Journal of Primatology|October 1, 2019
Baseline cortisol levels and social behavior differ as a function of handedness in marmosets (Callithrix jacchus)Emma Vaughan, Annie Le, Michaela Casey, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Clinical pharmacokinetics of oral CCNU (lomustine)F Y Lee, P Workman, J T Roberts, et al.
Carcinogenesis|August 1, 1994
Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductaseS A Fitzsimmons, A D Lewis, R J Riley, et al.
Biochemical Pharmacology|March 9, 1993
Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, SR 4233, WIN 59075)R J Riley, S A Hemingway, M A Graham, et al.
The British Journal of Radiology|November 1, 1983
The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicityD H Jones, N M Bleehen, P Workman, et al.
British Journal of Cancer|July 1, 1985
The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude miceP R Twentyman, P Workman, K A Wright, et al.
British Journal of Cancer|October 1, 1983
The role of dexamethasone in the modification of misonidazole pharmacokineticsD H Jones, N M Bleehen, P Workman, et al.
Oncogene|October 22, 2008
Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitorsJ R Smith, P A Clarke, E de Billy, et al.
British Journal of Cancer|June 1, 1993
Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell linesH M Coley, W B Amos, P R Twentyman, et al.
The British Journal of Radiology|February 1, 1986
A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokineticsJ T Roberts, N M Bleehen, M I Walton, et al.
Pageof 33